Statins’ potential to treat MS unrelated to lowering cholesterol

The common statin drug Simvastatin reduces brain atrophy and slows the progression of secondary progressive multiple sclerosis (SPMS). The effects appear to be independent of the drug’s cholesterol-lowering effects.
Author: neurosciencenews – robotics
Date/time: 11th May 2019, 15:08

About Christian

Talent Scout, Human Resource Management, Talent Management , Learning & Development, Organisational Development, Change Management, Psychology, Neuropsychology.

You May Also Like